Veritas Shoulder System
restor3d Inc. · Decision date Oct 22, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on 10/22/2026 for the Veritas Shoulder System, submitted by restor3d, inc. of Durham, North Carolina, under 510(k) number K263421. The device falls under the classification name Shoulder Prosthesis, Reverse Configuration, regulation number 888.3660, with primary product code PHX and subsequent product codes HSD and QHE. The application was received 09/25/2026 and reviewed by the Orthopedic panel; the record lists a Special summary, no third-party review, no combination product status, and no authorized predetermined change control plan.
SESE denotes 510(k) clearance of substantial equivalence to a legally marketed predicate, not premarket approval of the device itself. The public record does not identify the predicate device, the specific components or design changes assessed, or any performance data supporting the equivalence finding; those details would reside in the underlying review documents, which are not included here. No clinical, efficacy, or labeling conclusions are drawn from this decision record.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 22, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263421
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- restor3d Inc.
- Product code
- PHX
- Decision code
- SESE
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Shoulder Prosthesis, Reverse Configuration.
- Applicant
- restor3d Inc.
- Product code
- PHX
- FDA device class
- 2
FDA decision timeline
K263421 received
Application receipt date recorded by FDA.
K263421 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code PHX
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| FX Shoulder Solutions, Inc. | 510(k) clearance | Nov 5, 2026 | FDA | |
| ENCORE MEDICAL, L.P. | 510(k) clearance | Oct 2, 2026 | FDA | |
| Restor3D | 510(k) clearance | May 19, 2025 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
restor3d Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Durham, NC
Sources and methodology
- Original FDA record: K263421
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

